Home CUSTOMERS Bratislava Medical Journal 2018 Bratislava Medical Journal Vol.119, No.7, p.454–457, 2018

Journal info


Published Monthly, in English
Founded: 1919
ISSN 0006-9248
(E)ISSN 1336-0345

Impact factor 1.564


Aims and Scope
Editorial Info
Submission Guidelines

Select Journal

Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Bratislava Medical Journal Vol.119, No.7, p.454–457, 2018

Title: ADAM 33 gene V4 C/G rs2787094 polymorphism in psoriasis
Author: R. Akcilar, N. D. Namdar, F. E. Kocak, Z. Bayat, H. Burhan

Abstract: AIMS: Psoriasis is a common chronic inflammatory disease. A disintegrin and metalloproteinase 33 (ADAM33) gene is the first novel susceptibility gene for asthma. The aim of this study was to investigate the relationship of ADAM 33 gene V4 C/G rs2787094 polymorphism with the risk of psoriasis in the Turkish population.
METHODS: ADAM33 gene polymorphism (V4 C/G rs2787094) was analyzed in 97 psoriasis patients and 50 healthy control subjects. This study was performed by polymerase chain reaction–based restriction fragment length polymorphism (PCR-RFLP) analysis.
RESULTS: There was no significant difference in ADAM33 genotype and allele distributions between psoriasis and control groups (p > 0.05).
CONCLUSIONS: ADAM33 V4 C/G rs2787094 polymorphism was not associated with psoriasis risk in the Turkish population. Larger studies with different ethnicities are needed to determine the impact of ADAM33 polymorphism on the risk of developing psoriasis (Tab. 3, Fig. 1, Ref. 16).

Keywords: ADAM 33, V4 C/G gene polymorphism, psoriasis.
Published online: 17-Jul-2018
Year: 2018, Volume: 119, Issue: 7 Page From: 454, Page To: 457

download file

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.